- Home
- BWLP vs PTGX Comparison
BWLP vs PTGX Comparison
Compare BWLP & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- PTGX
- Stock Information
- Founded
- BWLP 1935
- PTGX 2006
- Country
- BWLP Singapore
- PTGX United States
- Employees
- BWLP N/A
- PTGX N/A
- Industry
- BWLP Marine Transportation
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- PTGX Health Care
- Exchange
- BWLP Nasdaq
- PTGX Nasdaq
- Market Cap
- BWLP 1.8B
- PTGX 2.4B
- IPO Year
- BWLP N/A
- PTGX 2016
- Fundamental
- Price
- BWLP $11.24
- PTGX $48.88
- Analyst Decision
- BWLP
- PTGX Strong Buy
- Analyst Count
- BWLP 0
- PTGX 8
- Target Price
- BWLP N/A
- PTGX $66.50
- AVG Volume (30 Days)
- BWLP 450.1K
- PTGX 1.7M
- Earning Date
- BWLP 02-27-2025
- PTGX 05-06-2025
- Dividend Yield
- BWLP 21.44%
- PTGX N/A
- EPS Growth
- BWLP N/A
- PTGX N/A
- EPS
- BWLP 2.64
- PTGX 4.23
- Revenue
- BWLP $3,563,747,000.00
- PTGX $434,433,000.00
- Revenue This Year
- BWLP N/A
- PTGX N/A
- Revenue Next Year
- BWLP $3.27
- PTGX $8.12
- P/E Ratio
- BWLP $4.74
- PTGX $11.56
- Revenue Growth
- BWLP 20.91
- PTGX 624.05
- 52 Week Low
- BWLP $9.95
- PTGX $24.22
- 52 Week High
- BWLP $22.31
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- BWLP 46.47
- PTGX 53.01
- Support Level
- BWLP $10.88
- PTGX $51.06
- Resistance Level
- BWLP $11.85
- PTGX $53.70
- Average True Range (ATR)
- BWLP 0.29
- PTGX 2.58
- MACD
- BWLP 0.06
- PTGX -0.81
- Stochastic Oscillator
- BWLP 68.07
- PTGX 0.72
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.